271 related articles for article (PubMed ID: 26080370)
1. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants.
Nunes MC; Cutland CL; Dighero B; Bate J; Jones S; Hugo A; van Niekerk N; Kuwanda L; Izu A; Weinberg A; Madhi SA;
J Infect Dis; 2015 Dec; 212(12):1976-87. PubMed ID: 26080370
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccination of pregnant women and protection of their infants.
Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.
Abzug MJ; Nachman SA; Muresan P; Handelsman E; Watts DH; Fenton T; Heckman B; Petzold E; Weinberg A; Levin MJ;
Clin Infect Dis; 2013 May; 56(10):1488-97. PubMed ID: 23378284
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial.
Nunes MC; Cutland CL; Moultrie A; Jones S; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Weinberg A; Madhi SA;
Lancet HIV; 2020 Feb; 7(2):e91-e103. PubMed ID: 31911146
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial.
Vesikari T; Virta M; Heinonen S; Eymin C; Lavis N; Chabanon AL; Gresset-Bourgeois V
Hum Vaccin Immunother; 2020 Mar; 16(3):623-629. PubMed ID: 31526225
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.
Munoz FM; Patel SM; Jackson LA; Swamy GK; Edwards KM; Frey SE; Petrie CR; Sendra EA; Keitel WA
Vaccine; 2020 Jul; 38(33):5355-5363. PubMed ID: 32571718
[TBL] [Abstract][Full Text] [Related]
7. Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.
Garg S; Thongcharoen P; Praphasiri P; Chitwarakorn A; Sathirapanya P; Fernandez S; Rungrojcharoenkit K; Chonwattana W; Mock PA; Sukwicha W; Katz JM; Widdowson MA; Curlin ME; Gibbons RV; Holtz TH; Dawood FS; Olsen SJ
Clin Infect Dis; 2016 Feb; 62(3):383-391. PubMed ID: 26486702
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn.
Blanchard-Rohner G; Meier S; Bel M; Combescure C; Othenin-Girard V; Swali RA; Martinez de Tejada B; Siegrist CA
Pediatr Infect Dis J; 2013 Dec; 32(12):1374-80. PubMed ID: 24569309
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants.
D'Angio CT; Heyne RJ; Duara S; Holmes LC; O'Shea TM; Wang H; Wang D; Sánchez PJ; Welliver RC; Ryan RM; Schnabel KC; Hall CB;
Pediatr Infect Dis J; 2011 Jul; 30(7):570-4. PubMed ID: 21273938
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
Nakphook S; Patumanond J; Shrestha M; Prasert K; Chittaganpitch M; Mott JA; Praphasiri P
PLoS One; 2021; 16(6):e0253028. PubMed ID: 34106994
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.
Mutsaerts E; Madhi SA; Cutland CL; Jones S; Hugo A; Trenor S; Treurnicht FK; Klipstein-Grobusch K; Weinberg A; Nunes MC
Expert Rev Vaccines; 2016 Aug; 15(8):1055-62. PubMed ID: 27212228
[TBL] [Abstract][Full Text] [Related]
12. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
13. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
Tsatsaris V; Capitant C; Schmitz T; Chazallon C; Bulifon S; Riethmuller D; Picone O; Poulain P; Lewin F; Lainé F; Jacqz-Aigrain E; Aboulker JP; Launay O;
Ann Intern Med; 2011 Dec; 155(11):733-41. PubMed ID: 22147712
[TBL] [Abstract][Full Text] [Related]
14. Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
Jallow S; Cutland CL; Masbou AK; Adrian P; Madhi SA
J Clin Virol; 2017 Sep; 94():50-56. PubMed ID: 28759772
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccination during pregnancy and its usefulness to mothers and their young infants.
Takeda S; Hisano M; Komano J; Yamamoto H; Sago H; Yamaguchi K
J Infect Chemother; 2015 Apr; 21(4):238-46. PubMed ID: 25708925
[TBL] [Abstract][Full Text] [Related]
16. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials.
Madhi SA; Nunes MC; Weinberg A; Kuwanda L; Hugo A; Jones S; van Niekerk N; Ortiz JR; Neuzil KM; Klugman KP; Simões EAF; Cutland CL;
Clin Infect Dis; 2017 Jun; 64(12):1773-1779. PubMed ID: 28369198
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of HIV-infected pregnant women: implications for protection of their young infants.
Dangor Z; Nunes MC; Kwatra G; Lala SG; Madhi SA
Trop Dis Travel Med Vaccines; 2017; 3():1. PubMed ID: 28883971
[TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M
Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270
[TBL] [Abstract][Full Text] [Related]
20. Neutralization and hemagglutination-inhibition antibodies following influenza vaccination of HIV-infected and HIV-uninfected pregnant women.
Nunes MC; Weinberg A; Cutland CL; Jones S; Wang D; Dighero-Kemp B; Levine MZ; Wairagkar N; Madhi SA
PLoS One; 2018; 13(12):e0210124. PubMed ID: 30596775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
